Kestra Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Sell
611
-35
-5% -$16.8K 0.01% 416
2026
Q1
$317K Buy
646
+18
+3% +$9.77K 0.01% 355
2025
Q4
$364K Sell
628
-99
-14% -$56K 0.01% 327
2025
Q3
$353K Sell
727
-62
-8% -$28.9K 0.01% 328
2025
Q2
$320K Buy
789
+53
+7% +$22.2K 0.01% 352
2025
Q1
$366K Buy
736
+389
+112% +$211K 0.01% 306
2024
Q4
$180K Sell
347
-532
-61% -$292K 0.01% 371
2024
Q3
$544K Buy
+879
New +$520K 0.02% 202

Other funds holding TMO

Kestra Investment Management's TMO Position: Q2 2026 in Review

Kestra Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 5.4% in Q2 2026, selling an estimated $16.8K and leaving 611 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #416.

Kestra Investment Management first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. The position peaked at $544K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Kestra Investment Management held 611 shares of Thermo Fisher Scientific worth $306K as of Q2 2026.
  • Kestra Investment Management sold 35 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.8K.
  • Thermo Fisher Scientific made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #416 holding.
  • Kestra Investment Management first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • Kestra Investment Management's Thermo Fisher Scientific position peaked at $544K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.